Lead Product(s) : Septrin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : National Institute of Allergy and Infectious Diseases | Fogarty International Center of the National Institute of Health | Harvard Initiative for Global Health | American Society of Tropical Medicine and Hygiene
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 15, 2010
Lead Product(s) : Septrin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : National Institute of Allergy and Infectious Diseases | Fogarty International Center of the National Institute of Health | Harvard Initiative for Global Health | American Society of Tropical Medicine and Hygiene
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
